Twist falls on larger-than-expected quarterly loss

Twist Bioscience

02/08/2024 17:39

** Shares of synthetic biology company Twist Bioscience
 TWST.O  fall about 14.5% to $45.30
    ** Company reports Q3 loss of $1.47/shr vs analysts' average
loss est. of 77 cents/shr - LSEG data
    ** TWST's quarterly revenue of $81.5 mln beats analysts'
average expectation of $77.4 mln
        ** Ten of 12 brokerages rate stock "buy" or higher, one
"hold" and one "sell" or lower; their median PT is $54 - LSEG
data
    ** Stock up 23.1% YTD    

 (Reporting by Christy Santhosh)
 ((Christy.Santhosh@thomsonreuters.com))